Skip to main content

BMS 527 Pill - white round, 6mm

Generic Name: dasatinib

Pill with imprint BMS 527 is White, Round and has been identified as Sprycel 20 mg. It is supplied by Bristol-Myers Squibb.

Sprycel is used in the treatment of Chronic Myelogenous Leukemia; Acute Lymphoblastic Leukemia; Leukemia and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Sprycel 20 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for BMS 527

Sprycel 20 mg BMS 527
Sprycel 20 mg BMS 527

Sprycel

Generic Name
dasatinib
Imprint
BMS 527
Strength
20 mg
Color
White
Size
6.00 mm
Shape
Round
Availability
Prescription only
Drug Class
BCR-ABL tyrosine kinase inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Bristol-Myers Squibb
National Drug Code (NDC)
00003-0527
Inactive Ingredients
lactose monohydrate, microcrystalline cellulose, croscarmellose sodium, magnesium stearate, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.